Ryvu Therapeutics Statistics
Total Valuation
WSE:RVU has a market cap or net worth of PLN 601.12 million. The enterprise value is 485.72 million.
Market Cap | 601.12M |
Enterprise Value | 485.72M |
Important Dates
The last earnings date was Friday, March 14, 2025.
Earnings Date | Mar 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
WSE:RVU has 23.12 million shares outstanding. The number of shares has increased by 0.97% in one year.
Current Share Class | n/a |
Shares Outstanding | 23.12M |
Shares Change (YoY) | +0.97% |
Shares Change (QoQ) | -4.26% |
Owned by Insiders (%) | 23.80% |
Owned by Institutions (%) | 52.82% |
Float | 15.70M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 5.90 |
PB Ratio | 4.18 |
P/TBV Ratio | 4.43 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.36 |
EV / Sales | 4.76 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -3.59 |
Financial Position
The company has a current ratio of 2.52, with a Debt / Equity ratio of 0.77.
Current Ratio | 2.52 |
Quick Ratio | 2.34 |
Debt / Equity | 0.77 |
Debt / EBITDA | n/a |
Debt / FCF | -0.82 |
Interest Coverage | -32.03 |
Financial Efficiency
Return on equity (ROE) is -55.24% and return on invested capital (ROIC) is -29.11%.
Return on Equity (ROE) | -55.24% |
Return on Assets (ROA) | -19.50% |
Return on Invested Capital (ROIC) | -29.11% |
Return on Capital Employed (ROCE) | -45.03% |
Revenue Per Employee | 310,857 |
Profits Per Employee | -339,741 |
Employee Count | 328 |
Asset Turnover | 0.26 |
Inventory Turnover | 11.77 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.91% in the last 52 weeks. The beta is 0.63, so WSE:RVU's price volatility has been lower than the market average.
Beta (5Y) | 0.63 |
52-Week Price Change | -55.91% |
50-Day Moving Average | 24.61 |
200-Day Moving Average | 42.14 |
Relative Strength Index (RSI) | 52.24 |
Average Volume (20 Days) | 129,374 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, WSE:RVU had revenue of PLN 101.96 million and -111.44 million in losses. Loss per share was -4.82.
Revenue | 101.96M |
Gross Profit | 82.38M |
Operating Income | -121.97M |
Pretax Income | -111.14M |
Net Income | -111.44M |
EBITDA | -111.76M |
EBIT | -121.97M |
Loss Per Share | -4.82 |
Balance Sheet
The company has 225.93 million in cash and 110.53 million in debt, giving a net cash position of 115.40 million or 4.99 per share.
Cash & Cash Equivalents | 225.93M |
Total Debt | 110.53M |
Net Cash | 115.40M |
Net Cash Per Share | 4.99 |
Equity (Book Value) | 143.88M |
Book Value Per Share | 6.22 |
Working Capital | 164.51M |
Cash Flow
In the last 12 months, operating cash flow was -129.48 million and capital expenditures -5.90 million, giving a free cash flow of -135.38 million.
Operating Cash Flow | -129.48M |
Capital Expenditures | -5.90M |
Free Cash Flow | -135.38M |
FCF Per Share | -5.86 |
Margins
Gross margin is 80.80%, with operating and profit margins of -119.63% and -109.29%.
Gross Margin | 80.80% |
Operating Margin | -119.63% |
Pretax Margin | -109.00% |
Profit Margin | -109.29% |
EBITDA Margin | -109.61% |
EBIT Margin | -119.63% |
FCF Margin | n/a |
Dividends & Yields
WSE:RVU does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.97% |
Shareholder Yield | -0.97% |
Earnings Yield | -18.54% |
FCF Yield | -22.52% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
WSE:RVU has an Altman Z-Score of 2.4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.4 |
Piotroski F-Score | n/a |